Correspondence 0001104659-23-128381 from TriSalus Life Sciences, Inc. (TLSI)
TriSalus Life Sciences, Inc.
Date: Dec. 21, 2023 · CIK: 0001826667 · Accession: 0001104659-23-128381
AI Filing Summary & Sentiment
File numbers found in text: 333-274292
Show Raw Text
CORRESP
1
filename1.htm
TriSalus
Life Sciences, Inc.
6272 W. 91st Ave.
Westminster, Colorado 80031
December 21, 2023
Securities and Exchange Commission
Division of Corporation Finance
Office of Technology
100 F. Street N.E.
Washington, D.C. 20549-3010
Attention: Juan Grana, Abby Adams
Re: TriSalus Life
Sciences, Inc.
Amendment No. 3 to Registration Statement
on Form S-1
File No. 333-274292
Ladies and Gentlemen:
TriSalus Life Sciences, Inc. (the “Registrant”)
hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause
the above-referenced Amendment No. 3 to Registration Statement on Form S-1 to become effective on Tuesday, December 26,
2023, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via
telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP, counsel to the Registrant,
to make such request on its behalf.
Once the Registration Statement has been declared
effective, please orally confirm that event with Carlos Ramirez of Cooley LLP, counsel to the Registrant, at (858) 550-6157.
[Signature Page Follows]
Very truly yours,
TRISALUS LIFE SCIENCES, INC.
By: /s/ Mary Szela
Name: Mary Szela
Title: Chief Executive
Officer
cc: Carlos Ramirez, Cooley LLP
Matthew T. Browne, Cooley LLP
[COMPANY
SIGNATURE PAGE TO ACCELERATION REQUEST]